Press releases
- Update on GSK actions to support the global response to COVID-19
- GSK appoints Charles Bancroft to the Board as a Non-Executive Director
- ViiV Healthcare announces first global regulatory approval of CABENUVA; the first complete, long-acting, regimen for the treatment of HIV
Tweets from GSK US
-
GSKUS @GSKUS
Defeating #COVID19 requires a collective effort from everyone working in healthcare. We’re collaborating with partners across the world to find a COVID-19 vaccine. Read more: gsk.to/39sfOmU
about 5 days ago
-
GSKUS @GSKUS
Today is #NationalDoctorsDay! On behalf of all of us at GSK, we’d like to thank all the #doctors and healthcare professionals on the front line working to keep us and the ones we love healthy and safe. 👩⚕️👨gsk.to/3dGMVXgAxQl
about 6 days ago -
GSKUS @GSKUS
Living with chronic conditions like #asthma or #COPD puts you at a higher risk for serious complications from #COVID19. Check out the @CDCgov's recommendations for #socialdistancing. twitter.com/CDCgov/status/…
about 8 days ago
